Marais, A. David

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

Cuchel, M., Meagher, E. A., du Toit Theron, H., Blom, D. J., Marais, A. D., Hegele, R. A., Averna, M. R., Sirtori, C. R., Shah, P. K., Gaudet, D., et al. (2013) · The Lancet

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 744

Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease

Marais, A. D. (2019) · Pathology

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 382

Familial dysbetalipoproteinemia: An underdiagnosed lipid disorder

Koopal, C., Marais, A. D., & Visseren, F. L. J. (2017) · Current Opinion in Endocrinology, Diabetes & Obesity

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 101

Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis

Clee, S. M., Bissada, N., Miao, F., Miao, L., Marais, A. D., Henderson, H. E., Steures, P., McManus, J., McManus, B., LeBoeuf, R. C., et al. (2000) · Journal of Lipid Research

Lipid metabolism and disordersCholesterol and Lipid Metabolism

Cited by 101

Dysbetalipoproteinaemia: A mixed hyperlipidaemia of remnant lipoproteins due to mutations in apolipoprotein E

Marais, A. D., Solomon, G. A. E., & Blom, D. J. (2014) · Critical Reviews in Clinical Laboratory Sciences

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 70

Autosomal dominant familial dysbetalipoproteinemia: A pathophysiological framework and practical approach to diagnosis and therapy

Koopal, C., Marais, A. D., Westerink, J., & Visseren, F. L. J. (2017) · Journal of Clinical Lipidology

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 53

The apolipoprotein E2 (Arg145Cys) mutation causes autosomal dominant type III hyperlipoproteinemia with incomplete penetrance.

de Villiers, W. J. S., van der Westhuyzen, D. R., Coetzee, G. A., Henderson, H. E., & Marais, A. D. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 41

Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene

Heidemann, B. E., Koopal, C., Baass, A., Defesche, J. C., Zuurbier, L., Mulder, M. T., Roeters van Lennep, J. E., Riksen, N. P., Boot, C., Marais, A. D., et al. (2022) · Clinical Genetics

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 27

Adiposity and the development of dyslipidemia in APOE ε2 homozygous subjects: A longitudinal analysis in two population-based cohorts

Heidemann, B. E., Wolters, F. J., Kavousi, M., Gruppen, E. G., Dullaart, R. P., Marais, A. D., Visseren, F. L., & Koopal, C. (2021) · Atherosclerosis

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 21